Skip to main content
TipRanks
Go Ultimate75% OFF

Nova Eye Medical (EYE) Stock Statistics & Valuation Metrics

21 Followers

Total Valuation

Nova Eye Medical has a market cap or net worth of AUD 44.16M. The enterprise value is AUD 31.34M.

Market Cap
AUD 44.16M
Enterprise Value
AUD 31.34M

Share Statistics

Nova Eye Medical has 284,921,080 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
284,921,080
Owned by Insiders
0.49%
Owned by Institutions
―

Financial Efficiency

Nova Eye Medical’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -26.25%.

Return on Equity (ROE)
-0.30
Return on Assets (ROA)
-0.20
Return on Invested Capital (ROIC)
-26.25%
Return on Capital Employed (ROCE)
-0.27
Revenue Per Employee
115.83K
Profits Per Employee
-14.40K
Employee Count
301
Asset Turnover
1.62
Inventory Turnover
3.04

Valuation Ratios

The current PE Ratio of Nova Eye Medical is -10.20. Nova Eye Medical’s PEG ratio is -0.12.

PE Ratio
-10.20
PS Ratio
1.27
PB Ratio
3.09
Price to FCF
-13.16
Price to Operating Cash Flow
-14.14
PEG Ratio
-0.12

Income Statement

In the last 12 months, Nova Eye Medical had revenue of 34.87M and earned -4.33M in profits. Earnings per share was -0.02.

Revenue
34.87M
Gross Profit
25.01M
Operating Income
-4.38M
Pretax Income
-4.33M
Net Income
-4.33M
EBITDA
-2.21M
Earnings Per Share (EPS)
-0.02

Cash Flow

In the last 12 months, operating cash flow was -3.12M and capital expenditures -235,000, giving a free cash flow of -3.36M billion.

Operating Cash Flow
-3.12M
Free Cash Flow
-3.36M
Free Cash Flow per Share
-0.01

Dividends & Yields

Nova Eye Medical pays an annual dividend of AUD 0.41, resulting in a dividend yield of ―

Dividend Per Share
AUD 0.41
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-7.60%
Earnings Yield
-9.81%

Stock Price Statistics

Beta
0.77
52-Week Price Change
19.23%
50-Day Moving Average
0.14
200-Day Moving Average
0.13
Relative Strength Index (RSI)
58.82
Average Volume (3m)
195.28K

Important Dates

Nova Eye Medical upcoming earnings date is Mar 02, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 26, 2026
Next Earnings Date
Mar 02, 2027
Ex-Dividend Date
Jul 21, 2020

Financial Position

Nova Eye Medical as a current ratio of 1.74, with Debt / Equity ratio of 16.77%

Current Ratio
1.74
Quick Ratio
1.15
Debt to Market Cap
0.02
Net Debt to EBITDA
-0.65
Interest Coverage Ratio
-28.41

Taxes

In the past 12 months, Nova Eye Medical has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Nova Eye Medical EV to EBITDA ratio is -20.65, with an EV/FCF ratio of -13.58.

EV to Sales
1.31
EV to EBITDA
-20.65
EV to Free Cash Flow
-13.58
EV to Operating Cash Flow
-14.60

Balance Sheet

Nova Eye Medical has AUD 964.00K in cash and marketable securities with AUD 2.39M in debt, giving a net cash position of -AUD 1.43M billion.

Cash & Marketable Securities
AUD 964.00K
Total Debt
AUD 2.39M
Net Cash
-AUD 1.43M
Net Cash Per Share
-AUD 0.01
Tangible Book Value Per Share
AUD 0.02

Margins

Gross margin is 71.74%, with operating margin of -12.55%, and net profit margin of -12.43%.

Gross Margin
71.74%
Operating Margin
-12.55%
Pretax Margin
-12.43%
Net Profit Margin
-12.43%
EBITDA Margin
-6.33%
EBIT Margin
-12.55%

Analyst Forecast

The average price target for Nova Eye Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
19.13%
EPS Growth Forecast
58.47%

Scores

Smart Score
4
AI Score
52